SecBot SecBot
3 ·Filed Jun 23, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001291963-26-000007
Form 3, initial insider ownership statement
Actionable Insight • Neutral

No immediate trading implications. Monitor for future Form 4 filings to see if Greene acquires or disposes of shares.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$20.33
T+0 close · Jun 23, 2026 · via day close
Latest settled
−11.17%
T+60 · $18.06
Vs SPY
−15.17%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 24 $20.33entry
  2. T+1 · 5mo ago +1.38%α +1.23% · $20.61
  3. T+5 · 5mo ago +7.18%α +5.47% · $21.79
  4. T+20 · 4mo ago +14.17%α +12.23% · $23.21
  5. T+60 · 2mo ago −11.17%α −15.17% · $18.06
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Barry Greene filed an initial beneficial ownership statement (Form 3) with the SEC, indicating he has become an officer, director, or 10% shareholder of Dyne Therapeutics. The filing includes a standard limited power of attorney for Section 16 reporting. No transactions or holdings were disclosed.

Key Facts

  • Form 3 filed by Barry Greene on June 22, 2026
  • Powers of attorney granted for Section 16 filings
  • No securities transactions or holdings reported in this filing

Financial Impact

No financial impact; routine administrative filing.

Risk Factors

  • None from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001291963-26-000007
Document: 0001291963-26-000007-index-headers.html0001291963-26-000007
Document: 0001291963-26-000007-index.html0001291963-26-000007
Document: 0001291963-26-000007.txt0001291963-26-000007

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (11h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 23, 2026